Literature DB >> 21977167

Mortality Risk and Etiologic Spectrum of Community-acquired Pneumonia in Hospitalized Adult Patients.

Cornelia Tudose1, Adriana Moisoiu, Miron Bogdan.   

Abstract

BACKGROUND: The etiology of community-acquired pneumonia (CAP) is specific to each region, as proved by numerous studies conducted so far. Knowledge of these data is essential in developing guidelines for antibiotic prescription. Assessment of severity of CAP patients is crucial in determining the risk of mortality and the site of care. Unusual bacterial etiologies may increase the risk of mortality.
OBJECTIVE: First outcome was the identification of pathogens in CAP patients requiring hospitalization and secondary to determine factors that correlate with increased risk of mortality.
MATERIAL AND METHODS: A prospective study of patients over 18 years of age hospitalized with CAP from whom pathological products were taken (mainly sputum) for bacteriological analysis (microscopy and culture).
RESULTS: 120 patients were evaluated over a period of three years (2008-2010); we could identify a bacterial etiology in 33 cases (27.5%). The most commonly isolated were S. pneumoniae (11 cases), H. influenzae (9 cases) and Gram-negative enteric bacilli (12 cases). The mortality rate was 9.2%, significantly higher in the age group over 65 years and in patients with hypoxemia, impaired consciousness and high CURB 65 score, but the only independent factor for the mortality risk prediction was the presence of confusion on admission.
CONCLUSIONS: S. pneumoniae, H. infuenzae and enteric Gram negative bacilli remain the most frequent cause of CAP in hospitalized patients in Romania and the first line of antibiotic treatment should be targeted. The only independent risk factor for mortality risk was the presence of disorders of consciousness on admission.

Entities:  

Keywords:  breast cancer; bronchoalveolar lavage; lymphocytosis; radiation pneumonitis

Year:  2010        PMID: 21977167      PMCID: PMC3152844     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  15 in total

1.  Etiologic diagnosis of adult bacterial pneumonia by culture and PCR applied to respiratory tract samples.

Authors:  Kristoffer Strålin; Eva Törnqvist; Margit Staum Kaltoft; Per Olcén; Hans Holmberg
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

2.  Assessment of the usefulness of sputum Gram stain and culture for diagnosis of community-acquired pneumonia requiring hospitalization.

Authors:  Naoyuki Miyashita; Hiroki Shimizu; Kazunobu Ouchi; Kozo Kawasaki; Yasuhiro Kawai; Yasushi Obase; Yoshihiro Kobashi; Mikio Oka
Journal:  Med Sci Monit       Date:  2008-04

3.  Definite, probable, and possible bacterial aetiologies of community-acquired pneumonia at different CRB-65 scores.

Authors:  Kristoffer Strålin; Per Olcén; Eva Törnqvist; Hans Holmberg
Journal:  Scand J Infect Dis       Date:  2010-07

4.  Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia.

Authors:  M M van der Eerden; F Vlaspolder; C S de Graaff; T Groot; H M Jansen; W G Boersma
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-04       Impact factor: 3.267

5.  Validation of a predictive rule for the management of community-acquired pneumonia.

Authors:  A Capelastegui; P P España; J M Quintana; I Areitio; I Gorordo; M Egurrola; A Bilbao
Journal:  Eur Respir J       Date:  2006-01       Impact factor: 16.671

6.  Mixed community-acquired pneumonia in hospitalised patients.

Authors:  A de Roux; S Ewig; E García; M A Marcos; J Mensa; H Lode; A Torres
Journal:  Eur Respir J       Date:  2006-04       Impact factor: 16.671

7.  Aetiology and prediction of pneumonia in lower respiratory tract infection in primary care.

Authors:  Anette Holm; Joergen Nexoe; Lene A Bistrup; Svend S Pedersen; Niels Obel; Lars P Nielsen; Court Pedersen
Journal:  Br J Gen Pract       Date:  2007-07       Impact factor: 5.386

8.  Comparing the pneumonia severity index with CURB-65 in patients admitted with community acquired pneumonia.

Authors:  Michelle R Ananda-Rajah; Patrick G P Charles; Sharmila Melvani; Laurelle L Burrell; Paul D R Johnson; M Lindsay Grayson
Journal:  Scand J Infect Dis       Date:  2008

9.  The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.

Authors:  Patrick G P Charles; Michael Whitby; Andrew J Fuller; Robert Stirling; Alistair A Wright; Tony M Korman; Peter W Holmes; Keryn J Christiansen; Grant W Waterer; Robert J P Pierce; Barrie C Mayall; John G Armstrong; Michael G Catton; Graeme R Nimmo; Barbara Johnson; Michelle Hooy; M L Grayson
Journal:  Clin Infect Dis       Date:  2008-05-15       Impact factor: 9.079

10.  Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods.

Authors:  Niclas Johansson; Mats Kalin; Annika Tiveljung-Lindell; Christian G Giske; Jonas Hedlund
Journal:  Clin Infect Dis       Date:  2010-01-15       Impact factor: 9.079

View more
  3 in total

1.  Treatment with Atorvastatin Provides Additional Benefits to Imipenem in a Model of Gram-Negative Pneumonia Induced by Klebsiella pneumoniae in Mice.

Authors:  Talles Prosperi de Paula; Patrícia Campi Santos; Raquel Duque do Nascimento Arifa; Angélica T Vieira; Ludmila de Matos Baltazar; Thiago Vinícius Ávila; Caio Tavares Fagundes; Zélia Menezes Garcia; Renata Lacerda Lima; Mauro Martins Teixeira; Danielle G Souza
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

2.  Bacterial etiologies of five core syndromes: laboratory-based syndromic surveillance conducted in Guangxi, China.

Authors:  Baiqing Dong; Dabin Liang; Mei Lin; Mingliu Wang; Jun Zeng; Hezhuang Liao; Lingyun Zhou; Jun Huang; Xiaolin Wei; Guanyang Zou; Huaiqi Jing
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

Review 3.  Evolving Understanding of the Causes of Pneumonia in Adults, With Special Attention to the Role of Pneumococcus.

Authors:  Daniel M Musher; Michael S Abers; John G Bartlett
Journal:  Clin Infect Dis       Date:  2017-10-30       Impact factor: 9.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.